Hegemony of economic values in conducting clinical trials with a placebo‐control group to investigate the treatment of periodontitis in lower‐middle‐income countries

Developing World Bioethics 22 (4):231-252 (2021)
  Copy   BIBTEX

Abstract

This article analyzes the bioethical implications of using a control/placebo group when conducting clinical trials (CTs) investigating the treatment of periodontitis. For this, the deductive method was used, proposing the interrelation of values, and a scoping systematic review was carried out. A total of 53% of the CTs reviewed were performed in low- and middle-income (LMI) countries, and 92% used a control/placebo group as a comparison group. Although there is a gold standard for the adjunctive treatment of periodontitis, the research ethics committees of most of the analyzed studies approved the use of control/placebo groups for the performance of CTs that did not explore new therapeutic alternatives. In some cases, the CT protocols were not approved by ethics committees, nor was informed consent used. In the LMI countries, a shorter period of recruitment was observed for patients who attended universities and public hospitals. Likewise, most of the CTs reviewed had public funding, a significant amount of which came from the pharmaceutical industry. Only one CT reported the low economic and educational level of its participants. Furthermore, none of the authors of the reviewed CTs declared conflicts of interest. Although the axiology of techno-science always takes into account at least the epistemic, technical and economic value systems, the hegemony of the economic values imposed by the pharmaceutical industry is evident in the performance of CTs investigating the treatment of periodontitis in LMI countries.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,475

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
What questions can a placebo answer?Spencer Phillips Hey & Charles Weijer - 2016 - Monash Bioethics Review 34 (1):23-36.
The necessity and the value of placebo.Dr Ernst A. Singer - 2004 - Science and Engineering Ethics 10 (1):51-56.
Empirical evidence against placebo controls.Sadhvi Batra & Jeremy Howick - 2017 - Journal of Medical Ethics 43 (10):707-713.
The necessity and the value of placebo.Ernst A. Singer - 2004 - Science and Engineering Ethics 10 (1):51-56.

Analytics

Added to PP
2021-09-23

Downloads
14 (#981,381)

6 months
10 (#260,500)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references